Numinus Wellness Inc. (NUMIF)

Market Cap	12.47M -12.6%
Revenue (ttm)	4.71M +11.1%
Net Income	-10.62M
EPS	-0.03
Shares Out	320.55M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	30
Open	0.0340
Previous Close	0.0400
Day's Range	0.0307 - 0.0340
52-Week Range	0.0055 - 0.0560
Beta	2.59
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 2, 2026

About Numinus Wellness

Numinus Wellness Inc. provides psychedelic-assisted therapy training, lab testing, and psychotherapy services in Canada and the United States. The company operates through Clinical Research Operations and Practitioner Training segments. It also provides clinical research management services to academic institutions and biotechnology companies. In addition, the company engages in the provision of education and training for research and drug development organizations to support clinical trials and commercialization efforts. Numinus Wellness Inc. ...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1964
• Country: Canada
• Stock Exchange: OTCMKTS
• Ticker Symbol: NUMIF

Financial Performance

In fiscal year 2024, Numinus Wellness's revenue was 4.17 million, an increase of 11.08% compared to the previous year's 3.75 million. Losses were -19.64 million, -35.08% less than in 2023.

Financial numbers in CAD

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 28, 2026

Data Sources Report a data error